You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access
Last Updated: March 15, 2025
Accurate, objective, and timely intelligence
Other Sections: Biologics Excipients Drug Price Drug Sales Litigation Investigational Drugs AI Research Assistant
Search by drug name:
Note:
DrugPatentWatch® Estimated Upcoming Generic Entry Dates
Anticipated Loss-of-Exclusivity (LOE) dates for branded drugs
Upcoming 180-Day Patent Challenge Exclusivity Expirations
Possibility for unrestricted generic entry after patent challenge
Upcoming Litigation Opportunities
NCE Exclusivity Expirations
Tentative Approvals
Identify first generic entrants
Drug Name | Trial Type | Start Date |
---|---|---|
CHILDREN'S ADVIL | New Formulation | 2024-06-01 |
CHILDREN'S ADVIL | New Formulation | 2024-06-01 |
CHILDREN'S ADVIL | New Formulation | 2024-06-01 |
See More 'New Combination' Trials >>
See More 'New Dosage' Trials >>
See More 'New Formulation' Trials >>
See More OTC Trials >>
See All 505(b)(2) Clinical Trials >>
Search for Off-Patent Drugs by Number of Sources:
1 Source 2 Sources 3 Sources 4 Sources 1-4 SourcesSearch by company name:
SearchSearch by NDA number:
SearchSearch for a keyword (e.g. 'substantially') or a phrase (e.g. 'consisting essentially of') in patent claims:
Search
Search for drugs approved in:
These are patents which have been reported by the FDA since the last major update; they are not yet in the main database.
Applicant | Tradename | Patent |
Vertical Pharms | DSUVIA | 12,033,733 |
Amicus Therap Us | GALAFOLD | 12,042,488 |
Amicus Therap Us | GALAFOLD | 12,042,489 |
All Recent Patent Additions >>
Applicant | Tradename | Patent |
Eli Lilly And Co | RETEVMO | 10,172,851 |
Eli Lilly And Co | RETEVMO | 10,137,124 |
Eli Lilly And Co | RETEVMO | 10,112,942 |
Eli Lilly And Co | RETEVMO | 12,138,250 |
Tradename | Submission date |
LUPKYNIS | January 22, 2025 |
INGREZZA SPRINKLE | January 07, 2025 |
NUPLAZID | January 02, 2025 |
Tradename | Ingredient | Marketing Start |
IMPOYZ | clobetasol propionate | Feb 10, 2025 |
METROLOTION | metronidazole | Feb 10, 2025 |
ZYLOPRIM | allopurinol | Feb 05, 2025 |
Patents by country:
SearchSearch by MeSH Category:
Search
Search by dosage:
Search
Search by branded drug / ingredient name:
SearchSearch by branded drug / ingredient name:
Upgrade to a full subscription to unlock our entire dataset and to enjoy subscriber-only features.
Whether you need access for yourself or for your whole team, DrugPatentWatch offers subscription plans tailored to your needs. Attractive pricing is available for small groups or for enterprise-wide access.
For more information see the Plans and Pricing and Discount Schedule. Please contact us with any questions.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.